Ginkgo Bioworks Holdings, Inc. (DNA, DNABW)

CIK 1830214 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ginkgo Bioworks Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Aug 25, 202640001628280-26-058939
Aug 24, 20261440001959173-26-006388
Aug 17, 20261440001959173-26-006078
Aug 6, 202610-Q0001628280-26-054298
Aug 5, 20268-K0001628280-26-053319
Jul 30, 202640001628280-26-051087
Jul 30, 20268-K0001628280-26-051041
Jul 30, 202640001628280-26-051084
Jul 30, 202640001628280-26-051089
Jul 30, 2026SCHEDULE 13G/A0002012383-26-003187
Jul 20, 202640001628280-26-048832
Jul 17, 20261440001959173-26-005273
Jun 15, 202640001628280-26-043291
Jun 15, 202640001628280-26-043296
Jun 15, 202640001628280-26-043299
Jun 15, 202640001628280-26-043293
Jun 12, 20268-K0001628280-26-042932
Jun 10, 20261440001959173-26-004504
May 26, 202640001628280-26-038202
May 22, 20261440001959173-26-003936
May 15, 2026SCHEDULE 13G/A0000905148-26-002424
May 13, 20261440001959173-26-003544
May 7, 202610-Q0001628280-26-032116
May 7, 20268-K0001628280-26-032093
Apr 29, 2026DEF 14A0001628280-26-028377